Cite
Samuelov L, Bochner R, Magal L, et al. Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis. Exp Dermatol. 2021;doi: 10.1111/exd.14502.
Samuelov, L., Bochner, R., Magal, L., Malovitski, K., Sagiv, N., Nousbeck, J., Keren, A., Fuchs-Telem, D., Sarig, O., Gilhar, A., & Sprecher, E. (2021). Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis. Experimental dermatology, . https://doi.org/10.1111/exd.14502
Samuelov, Liat, et al. "Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis." Experimental dermatology vol. (2021). doi: https://doi.org/10.1111/exd.14502
Samuelov L, Bochner R, Magal L, Malovitski K, Sagiv N, Nousbeck J, Keren A, Fuchs-Telem D, Sarig O, Gilhar A, Sprecher E. Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis. Exp Dermatol. 2021 Nov 17; doi: 10.1111/exd.14502. Epub 2021 Nov 17. PMID: 34787924.
Copy
Download .nbib